Literature DB >> 9733735

Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor.

M V Govindan1, N Warriar.   

Abstract

N-terminal sequences involved in transcription activation by the human mineralocorticoid receptor (hMR) have yet to be defined. We have addressed this issue and generated overlapping internal deletion mutants hMRDelta59-162, hMRDelta59-247, hMRDelta59-328, hMRDelta162-247, hMRDelta247-328, hMRDelta247-382, and hMRDelta328-382 with intact DNA-binding and hormone-binding domains. A second set of mutant receptors with unique BglII sites was generated to facilitate the isolations of fragments. Immunodetection with anti-hMR peptide antibodies and hormone-binding assays showed that the mutations did not affect the expression of the receptors or ability to bind aldosterone. Distribution of aldosterone binding activity of wild type and deletion mutants expressed in HeLa cells was predominantly nuclear. Furthermore, deletion of sequences between 59 and 390 did not affect DNA binding activity. Transfection studies with HeLa cells revealed a region around residue 247 that was crucial for normal receptor function. Deletion of amino acids 59-162 did not affect the transcriptional activity of the hMR. However, deletion of sequences 247-382 and 328-382 markedly decreased the transcription activation function. The induction of the reporter gene by the chimera hGRDelta71-262/hMR328-382 was 2-fold higher than with the wild type hGR, but 200-fold when compared with hGRDelta71-262, indicating that the AF-1 domain is located between positions 328 and 382 in the hMR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733735     DOI: 10.1074/jbc.273.38.24439

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.

Authors:  Tomoshige Kino; Howard Jaffe; Niranjana D Amin; Mayukh Chakrabarti; Ya-Li Zheng; George P Chrousos; Harish C Pant
Journal:  Mol Endocrinol       Date:  2010-03-31

4.  Conformation of the mineralocorticoid receptor N-terminal domain: evidence for induced and stable structure.

Authors:  Katharina Fischer; Sharon M Kelly; Kate Watt; Nicholas C Price; Iain J McEwan
Journal:  Mol Endocrinol       Date:  2010-08-04

5.  Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.

Authors:  Hirochika Kitagawa; Junn Yanagisawa; Hiroaki Fuse; Satoko Ogawa; Yoshiko Yogiashi; Atsuro Okuno; Hiromichi Nagasawa; Toshihiro Nakajima; Toshio Matsumoto; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

6.  In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice.

Authors:  Manuela Alonso; Charles Goodwin; Xiaohui Liao; Tania Ortiga-Carvalho; Danielle S Machado; Fredric E Wondisford; Samuel Refetoff; Roy E Weiss
Journal:  Endocrinology       Date:  2009-04-30       Impact factor: 4.736

7.  Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment.

Authors:  Manuel Morales; Pablo Martín-Vasallo; Julio Ávila
Journal:  Biomedicines       Date:  2022-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.